corticosterone has been researched along with MPTP Neurotoxicity Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Morale, MC | 1 |
Serra, PA | 1 |
Delogu, MR | 1 |
Migheli, R | 1 |
Rocchitta, G | 1 |
Tirolo, C | 1 |
Caniglia, S | 1 |
Testa, N | 1 |
L'Episcopo, F | 1 |
Gennuso, F | 1 |
Scoto, GM | 1 |
Barden, N | 1 |
Miele, E | 1 |
Desole, MS | 1 |
Marchetti, B | 1 |
Ben-Shaul, Y | 1 |
Benmoyal-Segal, L | 1 |
Ben-Ari, S | 1 |
Bergman, H | 1 |
Soreq, H | 1 |
2 other studies available for corticosterone and MPTP Neurotoxicity Syndrome
Article | Year |
---|---|
Glucocorticoid receptor deficiency increases vulnerability of the nigrostriatal dopaminergic system: critical role of glial nitric oxide.
Topics: Animals; Corticosterone; Dopamine; Enzyme Inhibitors; Lysine; Macrophages; Mice; Mice, Transgenic; M | 2004 |
Adaptive acetylcholinesterase splicing patterns attenuate 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Behavior, Animal; Brain; Cell Count; Cholinesterase In | 2006 |